You are here

Article info

Article menu
Immune cell therapies and immune cell engineering
Original research
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity

Authors

  • Aubrey S Smith Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USADivision of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Hannah M Knochelmann Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USADivision of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Megan M Wyatt Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Guillermo O Rangel Rivera Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USADivision of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Amalia M Rivera-Reyes Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Connor J Dwyer Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA PubMed articlesGoogle scholar articles
  • Michael B Ware Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • Anna C Cole Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles
  • David M Neskey Department of Otolaryngology—Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Cell and Molecular Pharmacology and Developmental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA PubMed articlesGoogle scholar articles
  • Mark P Rubinstein Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA PubMed articlesGoogle scholar articles
  • Bei Liu Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA PubMed articlesGoogle scholar articles
  • Jessica E Thaxton Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAImmunotherapy Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA PubMed articlesGoogle scholar articles
  • Eric Bartee Department of Internal Medicine, Division of Molecular Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA PubMed articlesGoogle scholar articles
  • Chrystal M Paulos Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USADivision of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia, USADepartment of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA PubMed articlesGoogle scholar articles

Citation

Smith AS, Knochelmann HM, Wyatt MM, et al
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
Journal for ImmunoTherapy of Cancer 2022;10:e003078. doi: 10.1136/jitc-2021-003078
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.